Mecolvix

Mesalazine, the active ingredient in Mecolvix, is an aminosalicylate presented as a rectal formulation for rectal use. It is employed to treat inflammatory bowel diseases such as ulcerative colitis and Crohn's disease with colonic involvement, helping to reduce inflammation of the colon lining.

GNH USA supplies Mecolvix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mecolvix (mesalazine) is used in the management of inflammatory bowel disease, targeting colonic inflammation. - Ulcerative colitis: induces and maintains remission of colonic inflammation. - Crohn's disease (colonic involvement): reduces mucosal inflammation and related symptoms. - Maintenance therapy: helps prevent relapse of ulcerative colitis after induction of remission.

Mecolvix may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Rectal irritation or burning sensation - Abdominal pain or cramping - Nausea or mild vomiting - Headache - Diarrhea or flatulence

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis, angioedema) - Blood dyscrasias such as leukopenia or thrombocytopenia - Pancreatitis or myocarditis

Before initiating Mecolvix, clinicians should consider several safety measures. - Renal function: monitor kidney parameters before and during therapy. - Hepatic function: assess liver enzymes periodically. - Hypersensitivity: discontinue if signs of rash, swelling or breathing difficulty appear. - Severe ulcerative colitis: use with caution and under specialist supervision. - Concomitant anticoagulants: increase bleeding risk; monitor coagulation status. - Store at room temperature: keep in original packaging, protect from moisture and light.

Mecolvix can interact with several medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may enhance bleeding risk. - Methotrexate: combined use can increase hematologic toxicity. - Azathioprine: may potentiate bone marrow suppression. - Live vaccines: reduced efficacy and increased infection risk.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may lower contraceptive effectiveness. - Lithium: mesalazine can raise lithium serum levels. - Diuretics: may affect renal clearance of mesalazine. - Corticosteroids: concurrent use may increase risk of gastrointestinal complications.